Alzheimer's and Parkinson's Flashcards

1
Q

Dopamine and acetylcholine role in smooth movements

A

dopamine inhibits, acetylcholine excites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

neurotransmitters involved in parkinson’s

A

dopamine and acetylcholine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Most effective drug for Parkinson’s

A

Levodopa/carbidopa=sinemet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Levodopa mechanism of action

A

lifts dopamine levels by converting to dopamine in the brain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

carbidopa MOA

A

drives levodopa across the BBB by decreasing breakdown of levodopa in the periphery by DDC.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

how long does levodopa have an effect

A

about 5 years – often won’t use it in 60 year olds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What enzyme breaks down levodopa, allowing only 2% of blood to reach the brain

A

DDC. When carbidopa blocks that enzyme, 10% of it goes across the BBB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

SE of levodopa/carbidopa

A

MOST COMMON: n/v (don’t take with high-protein meals), dyskenesia
Other systems: CV postural hypotension, dysrhythmias; NEURO psychosis 20%, anxiety, agitation, memory but don’t use 1st gen antipsychotic; GU darkened sweat and urine; activate malignant melanoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Most common SE of levodopa/carbidopa

A

n/v, dyskinesia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Cardiovascular SE of Levodopa/Carbidopa

A

postural hypotension, dysrhythmias – sometimes need salt pills

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

CNS effects of levodopa/carbidopa

A

psychosis (but don’t use a 1st gen antipsychotic), anxiety, agitation, memory issues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Integumentary/excretion SE of levodopa/carbidopa

A
  • darkened sweat and urine

- maybe activate malignant melanoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Acute loss of effect for levodopa/carbidopa

A
  • wears off at end of the dosing interval

- minutes to hours where it stops working (avoid high protein meals)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Dopamine agonist prototype

A

pramipexole (Mirapex)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

1st line therapy for mild to moderate symptoms and for younger patients who are more likely to handle side effects

A

dopamine agonists: pramipexole

younger patients – the babies get pushed in the pram

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

weird side effect of pramipexole

A

pathological gambling and other compulsive self-rewarding behavior

17
Q

SE of monotherapy pramipexole

A

daytime sleepiness (sleep attack), insomnia, hallucinations, nausea, dizziness, constipation, weakness

18
Q

SE of levadopa + pramipexole

A

orthostatic hypotension, dyskinesia, double rate of hypotension

19
Q

what else is pramipexole used for

A

restless leg syndrome

20
Q

COMT inhibitor prototype

A

entacapone (comtan)

21
Q

Levodopa booster

A

COMT inhibitor – no direct therapeutic effects on their own

22
Q

SE of COMT inhibitors (entacapone)

A

increased levo SE, GI distress, yellow/orange discoloration of urine

23
Q

MAO-B inhibitors prototype

A

selegiline (Eldepryl)

24
Q

Why are MAO-B inhibitors used in parkinson’s

A

Reduce levodopa wearing-off effect, suppress destruction of dopamine and prolong the effects of levodopa

25
Q

SE of selegiline (MAO-B inhibitors)

A

insomnia, orthostatic hypotension, dizziness, GI symptoms

26
Q

Unexpected drug for parkinson’s

A

amantadine (antiviral)

27
Q

Why does an antiviral help with Parkinson’s

A

can help with dyskinesias caused by levodopa

28
Q

SE of amantadine for Parkinson’s

A

CNS, anticholinergic, benign livedo reticularis (mottled skin discoloration)

29
Q

anticholinergic prototype

A

benztropine (cogentin)

30
Q

who gets an anticholinergic for parkinson’s

A

younger patients – it’s on the BEERS list

31
Q

function of cholinesterase

A

breaks down acetylcholine

32
Q

MOA of cholinesterase inhibitors

A

Inhibits cholinesterase, making ACh available to neurons

33
Q

are cholinesterase inhibitors effective?

A

Ummm, statistically but not clinically. They also don’t bring back anything that’s already been lost.

34
Q

SE of cholinesterase inhibitors

A

pro-cholinergic: rest and digest, bronchoconstriction, n/d, bradycardia, fainting, falls

35
Q

Administration considerations for cholinesterase inhibitors

A

give at night, slowly titrate up

36
Q

NMDA receptor antagonists prototype

A

memantine (namenda)

37
Q

MOA for NMDA receptor antagonists (memantine)

A

allows calcium influx into neuron

38
Q

SE of memantine

A

related to toooooo much calcium entering: dizziness, headache, confusion, constipation (but very well tolerated)